A new report highlights the ways in which cybercriminals target people, rather than systems and infrastructure, to install malware, initiate fraudulent transactions, steal data, and more.
An estimated two million cyber attacks in 2018 resulted in more than $45 billion in losses worldwide as local governments struggled to cope with ransomware and other malicious incidents.
Two prolific dark web marketplaces have been taken down in simultaneous global operations supported by Europol: the Wall Street Market and the Silkkitie (known as the Valhalla Marketplace).
In 2018, we witnessed some of the biggest data breaches ever – affecting businesses and consumers alike. From social media, hospitality, healthcare and even mail delivery, 2018 proved that there is no escaping cybersecurity flaws, regardless of the type of business or its popularity. For example, we witnessed the data of approximately 500 million Marriot guests get breached and a USPS security flaw that exposed the personal data of more than 60 million people.
Cyberattacks and data breaches are inevitable, but a multifaceted security approach will limit the potential impact. A successful strategy will combine technology, processes and people.
The WannaCry ransomware attack that successfully targeted Merck is not the only cyberattack to which the pharmaceutical industry has fallen victim. As pharmaceutical and biotechnology companies move toward greater digitalization and the storage of more valuable data, their digital security practices become more and more critical.
Companies globally could incur $5.2 trillion in additional costs and lost revenue over the next five years due to cyberattacks, as dependency on complex internet-enabled business models outpaces the ability to introduce adequate safeguards that protect critical assets.